10.4049/jimmunol.0903856 25 MartensG
doi:10.1023/A:1018955126402 Ionescu M, Frohman LA
Data from this manuscript were published in abstract form in the proceedings of the 75th Annual Meeting of the American Diabetes Association, Boston, MA, USA, 59 June 2015
GSH is the smallest of the intracellular thiols (a compound that contains the functional group composed of a sulphur-hydrogen bond (-SH) hence its unpleasant smell when mercaptans are released) and its high donating electron capacity combined with dense intracellular concentration provides significant oxidative reducing capacity.[3] How can you take it and what are its suggested applications
Published research describes the following mechanisms for MC1R agonists like afamelanotide: NF-kappaB suppression reduced transcription of pro-inflammatory genes Cytokine modulation decreased TNF-alpha, IL-1beta, and IL-6 production Nitric oxide regulation normalization of NO pathway signaling Adhesion molecule downregulation reduced inflammatory cell migration IL-10 upregulation increased anti-inflammatory cytokine output These effects have been demonstrated in vitro and in animal models of acute, chronic, and systemic inflammation (Catania et al., 2004)